Atossa Genetics Stock Today
| ATOS Stock | USD 0.65 0.02 2.99% |
PerformanceWeakest
| Odds Of DistressLow
|
Atossa Genetics is selling for under 0.65 as of the 10th of January 2026; that is 2.99 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.63. Atossa Genetics has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of December 2025 and ending today, the 10th of January 2026. Click here to learn more.
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. The company has 129.17 M outstanding shares of which 2.28 M shares are presently shorted by private and institutional investors with about 2.17 trading days to cover. More on Atossa Genetics
Moving together with Atossa Stock
Moving against Atossa Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Atossa Stock Highlights
Atossa Genetics (ATOS) is traded on NASDAQ Exchange in USA and employs 15 people. Atossa Genetics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 83.33 M. Atossa Genetics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 129.17 M outstanding shares of which 2.28 M shares are presently shorted by private and institutional investors with about 2.17 trading days to cover.
Atossa Genetics currently holds about 125.54 M in cash with (21.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.99, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Atossa Genetics Probability Of Bankruptcy
Ownership AllocationAtossa Genetics holds a total of 129.17 Million outstanding shares. Almost 80.48 percent of Atossa Genetics outstanding shares are held by general public with 0.07 (percent) owned by insiders and only 19.45 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Atossa Ownership Details
Atossa Genetics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Atossa Genetics market risk premium is the additional return an investor will receive from holding Atossa Genetics long position in a well-diversified portfolio.
| Mean Deviation | 2.96 | |||
| Standard Deviation | 3.86 | |||
| Variance | 14.92 | |||
| Risk Adjusted Performance | (0.13) |
Atossa Stock Against Markets
Atossa Genetics Corporate Management
| RAC MSPH | VP of Regulatory Affairs and Quality | Profile | |
| Heather CPA | Senior Officer | Profile | |
| Michael Parks | Vice Relations | Profile | |
| Mark CPA | Chief Officer | Profile | |
| Heather Rees | VP Accounting | Profile | |
| FCAP MD | CEO Chairman | Profile | |
| Delly PHR | Senior Operations | Profile |
Already Invested in Atossa Genetics?
The danger of trading Atossa Genetics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Atossa Genetics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Atossa Genetics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Atossa Genetics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.